SCHEMBL13314765

SCHEMBL13314765

CCCC[C@@H]1CCc2sc(NC(=N)N)nc2C1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 8/20 0.37
LMNA P02545 4/20 0.37
SLC27A1 Q6PCB7 1/20 0.36
RAB9A P51151 4/20 0.35
NPC1 O15118 3/20 0.35
SMN1; SMN2 Q16637 3/20 0.35
ALDH1A1 P00352 4/20 0.34
THRB P10828 1/20 0.33
TSHR P16473 1/20 0.33
PDE4B Q07343 1/20 0.33
PDE4D Q08499 1/20 0.33
PARP1 P09874 1/20 0.32
NPSR1 Q6W5P4 1/20 0.32
TP53 P04637 4/20 0.31
HRH2 P25021 2/20 0.31
HRH1 P35367 2/20 0.31
HRH4 Q9H3N8 2/20 0.31
HRH3 Q9Y5N1 2/20 0.31
HSD17B10 Q99714 1/20 0.31
DRD2 P14416 2/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3531836 1.00 MAPT (0.37) MAPTLMNASLC27A1RAB9ANPC1
SCHEMBL13314767 0.93 NPC1 (0.37) MAPTLMNASLC27A1RAB9ANPC1
SCHEMBL13314762 0.83 RAB9A (0.44) MAPTLMNARAB9ANPC1SMN1; SMN2
SCHEMBL3542473 0.83 RAB9A (0.44) MAPTLMNARAB9ANPC1SMN1; SMN2
SCHEMBL3532844 0.78 RAB9A (0.52) MAPTLMNASLC27A1RAB9ANPC1
SCHEMBL13314761 0.78 RAB9A (0.52) MAPTLMNASLC27A1RAB9ANPC1
SCHEMBL4421639 0.74 RAB9A (0.44) MAPTLMNARAB9ANPC1SMN1; SMN2
SCHEMBL13570298 0.72 MAPT (0.47) MAPTLMNARAB9ANPC1SMN1; SMN2
SCHEMBL11241158 0.72 DRD2 (0.45) HRH2HRH1HRH4HRH3DRD2
SCHEMBL16993688 0.71 MAPT (0.31) MAPTLMNARAB9ANPC1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7727979-B2 Guanidine derivatives and their use as neuropeptide FF receptor antagonists ACTELION PHARMACEUTICALS LTD. (CH) 2010-06-01 US disclosed